STARD3: A New Biomarker in HER2-Positive Breast Cancer

SIMPLE SUMMARY: One out of 8 breast cancers is of a particular type called “HER2-positive”, which is more aggressive and is treated by surgery and a medical treatment associating chemotherapy and a targeted drug against the protein HER2, possibly followed by radiotherapy and endocrine therapy. When...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodi, Massimo, Voilquin, Laetitia, Alpy, Fabien, Molière, Sébastien, Reix, Nathalie, Mathelin, Carole, Chenard, Marie-Pierrette, Tomasetto, Catherine-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856516/
https://www.ncbi.nlm.nih.gov/pubmed/36672312
http://dx.doi.org/10.3390/cancers15020362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856516/
https://www.ncbi.nlm.nih.gov/pubmed/36672312
http://dx.doi.org/10.3390/cancers15020362

Ejemplares similares